Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 54 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.

    Reunala T, Salmi TT, Hervonen K

    Acta dermato-venereologica 2015; (95(8)):917-22 doi:10.2340/00015555-2162.

    PMID: 26059085
  2. 2

    Dermatitis Herpetiformis Refractory to Gluten-free Dietary Treatment.

    Hervonen K, Salmi TT, Ilus T, et al.

    Acta dermato-venereologica 2016; (96(1)):82-6 doi:10.2340/00015555-2184.

    PMID: 26084552
  3. 3

    Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.

    Hahn M, Hagel AF, Hirschmann S, et al.

    Allergo journal international 2014; (23(2)):67-77 doi:10.1007/s40629-014-0006-4.

    PMID: 26120517
  4. 4

    Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland.

    Pasternack C, Kaukinen K, Kurppa K, et al.

    American journal of clinical dermatology 2015; (16(6)):545-52 doi:10.1007/s40257-015-0149-1.

    PMID: 26267424
  5. 5

    Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis.

    Akasaka E, Kayo SJ, Nakano H, et al.

    Case reports in dermatology 2015; (7(2)):183-6 doi:10.1159/000438506.

    PMID: 26351428
  6. 6

    The Decreasing Prevalence of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients.

    Mansikka E, Hervonen K, Salmi TT, et al.

    Journal of clinical gastroenterology 2017; (51(3)):235-239 doi:10.1097/MCG.0000000000000533.

    PMID: 27136959
  7. 7

    Gastrointestinal Symptoms Increase the Burden of Illness in Dermatitis Herpetiformis: A Prospective Study.

    Pasternack C, Kaukinen K, Kurppa K, et al.

    Acta dermato-venereologica 2017; (97(1)):58-62 doi:10.2340/00015555-2471.

    PMID: 27241271
  8. 8

    Difference of the clinical course and outcome between dapsone-induced methemoglobinemia and other toxic-agent-induced methemoglobinemia.

    Kim YJ, Sohn CH, Ryoo SM, et al.

    Clinical toxicology (Philadelphia, Pa.) 2016; (54(7)):581-4 doi:10.1080/15563650.2016.1178759.

    PMID: 27412886
  9. 9

    Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.

    Collin P, Salmi TT, Hervonen K, et al.

    Annals of medicine 2017; (49(1)):23-31 doi:10.1080/07853890.2016.1222450.

    PMID: 27499257
  10. 10

    Dapsone-induced pure red cell aplasia and cholestatic jaundice: A new experience for diagnosis and management.

    Sawlani KK, Chaudhary SC, Singh J, et al.

    Journal of research in pharmacy practice 2016; (5(3)):215-8 doi:10.4103/2279-042X.185743.

    PMID: 27512715
  11. 11

    Rituximab Treatment for Recalcitrant Dermatitis Herpetiformis.

    Albers LN, Zone JJ, Stoff BK, Feldman RJ

    JAMA dermatology 2017; (153(3)):315-318 doi:10.1001/jamadermatol.2016.4676.

    PMID: 28030659
  12. 12

    The Inpatient Burden of Autoimmune Blistering Disease in US Children: Analysis of Nationwide Inpatient Sample Data.

    Ren Z, Hsu DY, Silverberg NB, Silverberg JI

    American journal of clinical dermatology 2017; (18(2)):287-297 doi:10.1007/s40257-017-0257-1.

    PMID: 28211027
  13. 13

    Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.

    Schiepatti A, Biagi F, Fraternale G, et al.

    European journal of gastroenterology & hepatology 2017; (29(5)):572-576 doi:10.1097/MEG.0000000000000836.

    PMID: 28350748
  14. 14

    Linear IgA bullous dermatosis mimicking oral lichen planus.

    Shah S, Mohr B, Parekh P

    Proceedings (Baylor University. Medical Center) 2017; (30(3)):360-361 doi:10.1080/08998280.2017.11929649.

    PMID: 28670088
  15. 15

    The Value of Direct Immunofluorescence on Proteinase-Digested Formalin-Fixed Paraffin-Embedded Skin Biopsies.

    Valencia-Guerrero A, Deng A, Dresser K, et al.

    The American Journal of dermatopathology 2018; (40(2)):111-117 doi:10.1097/DAD.0000000000000934.

    PMID: 28816740
  16. 16

    Trichoscopy - a useful tool in the preliminary differential diagnosis of autoimmune bullous diseases.

    Sar-Pomian M, Rudnicka L, Olszewska M

    International journal of dermatology 2017; (56(10)):996-1002 doi:10.1111/ijd.13725.

    PMID: 28856676
  17. 17

    The importance of direct immunofluorescence in pemphigus herpetiformis diagnosis.

    Faria PCP, Cruz CC, Abulafia LA, et al.

    Anais brasileiros de dermatologia 2017; (92(5 Suppl 1)):145-147 doi:10.1590/abd1806-4841.20174510.

    PMID: 29267475
  18. 18

    A retrospective study of dermatitis herpetiformis from an immunobullous disease clinic in north India.

    Handa S, Dabas G, De D, et al.

    International journal of dermatology 2018; (57(8)):959-964 doi:10.1111/ijd.14029.

    PMID: 29752728
  19. 19

    Dermatitis Herpetiformis: A Common Extraintestinal Manifestation of Coeliac Disease.

    Reunala T, Salmi TT, Hervonen K, et al.

    Nutrients 2018; (10(5)) doi:10.3390/nu10050602.

    PMID: 29757210
  20. 20

    Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis.

    Mansikka E, Hervonen K, Kaukinen K, et al.

    Nutrients 2018; (10(5)) doi:10.3390/nu10050641.

    PMID: 29783727
  21. 21

    Facial Involvement in Dermatitis Herpetiformis: A Case Report and Review of the Literature.

    Cinats AK, Parsons LM, Haber RM

    Journal of cutaneous medicine and surgery 2019; (23(1)):35-37 doi:10.1177/1203475418795818.

    PMID: 30103636
  22. 22

    Diagnosis of autoimmune bullous diseases.

    van Beek N, Zillikens D, Schmidt E

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(9)):1077-1091 doi:10.1111/ddg.13637.

    PMID: 30179336
  23. 23

    A Case of Dermatitis Herpetiformis With Fibrillar Immunoglobulin A Deposition: A Rare Pattern Not to Be Missed.

    Lilo MT, Yan S, Chapman MS, Linos K

    The American Journal of dermatopathology 2019; (41(7)):511-513 doi:10.1097/DAD.0000000000001380.

    PMID: 30839342
  24. 24

    [Dermatitis herpetiformis].

    Juratli HA, Görög A, Sárdy M

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(4)):260-264 doi:10.1007/s00105-019-4378-8.

    PMID: 30868254
  25. 25

    Dermatitis herpetiformis.

    Salmi TT

    Clinical and experimental dermatology 2019; (44(7)):728-731 doi:10.1111/ced.13992.

    PMID: 31093998
  26. 26

    Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology.

    Vale ECSD, Dimatos OC, Porro AM, Santi CG

    Anais brasileiros de dermatologia 2019; (94(2 Suppl 1)):48-55 doi:10.1590/abd1806-4841.2019940208.

    PMID: 31166403
  27. 27

    Dermatitis Herpetiformis: Novel Perspectives.

    Antiga E, Maglie R, Quintarelli L, et al.

    Frontiers in immunology 2019; (10()):1290 doi:10.3389/fimmu.2019.01290.

    PMID: 31244841
  28. 28

    Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.

    Bian Y, Kim K, An GJ, et al.

    Toxicological sciences : an official journal of the Society of Toxicology 2019; (172(2)):435-444 doi:10.1093/toxsci/kfz188.

    PMID: 31428780
  29. 29

    Update on the use of dapsone in dermatology.

    Ghaoui N, Hanna E, Abbas O, et al.

    International journal of dermatology 2020; (59(7)):787-795 doi:10.1111/ijd.14761.

    PMID: 31909480
  30. 30

    An update on direct immunofluorescence for diagnosing dermatitis herpetiformis.

    Dmochowski M, Gornowicz-Porowska J, Bowszyc-Dmochowska M

    Postepy dermatologii i alergologii 2019; (36(6)):655-658 doi:10.5114/ada.2019.91415.

    PMID: 31997990
  31. 31

    Current Concepts of Dermatitis Herpetiformis.

    Salmi T, Hervonen K

    Acta dermato-venereologica 2020; (100(5)):adv00056 doi:10.2340/00015555-3401.

    PMID: 32039457
  32. 32

    Mast cells and thymic stromal lymphopoietin (TSLP) expression positively correlates with pruritus intensity in dermatitis herpetiformis.

    Xia Q, Liu T, Wang J, et al.

    European journal of dermatology : EJD 2020; (30(5)):499-504 doi:10.1684/ejd.2020.3881.

    PMID: 33021479
  33. 33

    Dapsone-induced methemoglobinemia in pediatrics post-renal transplant.

    Hindka A, Huynh D, Verghese PS

    Pediatric transplantation 2021; (25(3)):e13921 doi:10.1111/petr.13921.

    PMID: 33280223
  34. 34

    Dermatitis Herpetiformis: An Update on Diagnosis and Management.

    Reunala T, Hervonen K, Salmi T

    American journal of clinical dermatology 2021; (22(3)):329-338 doi:10.1007/s40257-020-00584-2.

    PMID: 33432477
  35. 35

    Development of Dermatitis Herpetiformis in Chronic Plaque Psoriasis.

    Lee R, Lobo Y, Spelman L

    Case reports in dermatology 2021; (13(1)):141-147 doi:10.1159/000512870.

    PMID: 33790758
  36. 36

    Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.

    Kemppainen E, Salmi T, Lindfors K

    Frontiers in immunology 2021; (12()):657280 doi:10.3389/fimmu.2021.657280.

    PMID: 33854513
  37. 37

    Significant improvement of dermatitis herpetiformis with tofacitinib.

    Kahn JS, Moody K, Rosmarin D

    Dermatology online journal 2021; (27(7)) doi:10.5070/D327754365.

    PMID: 34391330
  38. 38

    Dermatitis Herpetiformis: An Update on Diagnosis, Disease Monitoring, and Management.

    Nguyen CN, Kim SJ

    Medicina (Kaunas, Lithuania) 2021; (57(8)) doi:10.3390/medicina57080843.

    PMID: 34441049
  39. 39

    [Dermatitis herpetiformis and celiac disease].

    García C, Araya M

    Revista medica de Chile 2021; (149(9)):1330-1338 doi:10.4067/S0034-98872021000901330.

    PMID: 35319687
  40. 40

    Etiopathogenesis of dermatitis herpetiformis.

    Rybak-d'Obyrn J, Placek W

    Postepy dermatologii i alergologii 2022; (39(1)):1-6 doi:10.5114/ada.2020.101637.

    PMID: 35369614
  41. 41

    A comprehensive insight into the anti-inflammatory properties of dapsone.

    Khalilzadeh M, Shayan M, Jourian S, et al.

    Naunyn-Schmiedeberg's archives of pharmacology 2022; (395(12)):1509-1523 doi:10.1007/s00210-022-02297-1.

    PMID: 36125533
  42. 42

    A Rare Case of COVID-19-Induced Acute Exacerbation of Oral Dermatitis Herpetiformis in a Geriatric Patient.

    Shafuria A, Sufiawati I, Usman HA

    International medical case reports journal 2023; (16()):129-134 doi:10.2147/IMCRJ.S401775.

    PMID: 36923800
  43. 43

    Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.

    Dziewulska KH, Reisz JA, Hay AM, et al.

    The Journal of pharmacology and experimental therapeutics 2023; (386(3)):323-330 doi:10.1124/jpet.123.001634.

    PMID: 37348965
  44. 44

    Clinicopathological Profile of Dermatitis Herpetiformis Patients in Saudi Arabia.

    Alasmari B, Alkhodair R

    Cureus 2023; (15(10)):e48045 doi:10.7759/cureus.48045.

    PMID: 38034235
  45. 45

    Dapsone-Induced Methemoglobinemia Presenting Concomitantly With COVID-19 Pneumonia and Pulmonary Embolism: A Case Report.

    Alhusari L, Pigliacampi M, Alshawabkeh Y, et al.

    Cureus 2024; (16(1)):e51830 doi:10.7759/cureus.51830.

    PMID: 38327942
  46. 46

    Celiac Disease-Related Conditions: Who to Test?

    Zingone F, Bai JC, Cellier C, Ludvigsson JF

    Gastroenterology 2024; (167(1)):64-78 doi:10.1053/j.gastro.2024.02.044.

    PMID: 38460606
  47. 47

    Diagnostic Utility of Direct Immunofluorescence on Paraffin-Embedded Skin Biopsy Samples for the Diagnosis of Autoimmune Vesiculobullous Lesions.

    Bk P, Panwar H, Joshi D, et al.

    Cureus 2024; (16(3)):e56916 doi:10.7759/cureus.56916.

    PMID: 38665766
  48. 48

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  49. 49

    A Comparative Study of Direct Immunofluorescence Patterns in Linear IgA Bullous Dermatosis Versus Dermatitis Herpetiformis.

    Sagut P, Lyles E, Vroman J, et al.

    The American Journal of dermatopathology 2024; (47(7)):505-511 doi:10.1097/DAD.0000000000002864.

    PMID: 39570799
  50. 50

    Methaemoglobinaemia as an Alternative Diagnosis for Shortness of Breath: A Case Report.

    Thiri T, San SS, Lwin ZT

    Cureus 2025; (17(5)):e83525 doi:10.7759/cureus.83525.

    PMID: 40470439
  51. 51

    The Dapsone Conundrum: Understanding Implications of Adverse Reactions to Dapsone Including Dapsone Hypersensitivity Syndrome in Leprosy Patients Treated With Multidrug Therapy.

    Dev A, Narang T, Thakur V, Dogra S

    International journal of dermatology 2025; (64(10)):1862-1869 doi:10.1111/ijd.17906.

    PMID: 40514800
  52. 52

    Unusual site presentation of dermatitis herpetiformis: line-field confocal optical coherence tomography for effective management.

    Bettolini L, Bighetti S, Rovaris S, et al.

    Dermatology reports 2025; doi:10.4081/dr.2025.10100.

    PMID: 40963385
  53. 53

    Slow Evolution of Non-Familial Autoimmune Polyglandular Syndrome Type II in A 54-Year-Old Female, First Presenting with Addison's Disease, then Hashimoto's Thyroiditis, which then Transitioned to Graves' Disease and then the Development of Type 1 Diabetes.

    E'leimat G, Nguyen TH, Thawani H

    European journal of case reports in internal medicine 2025; (12(10)):005779 doi:10.12890/2025_005779.

    PMID: 41064726
  54. 54

    Oral mucosa in dermatitis herpetiformis (Duhring's disease): a clinical and mycologic evaluation.

    Mania-Końsko A, Ślebioda Z, Wyganowska ML

    Oral surgery, oral medicine, oral pathology and oral radiology 2025; doi:10.1016/j.oooo.2025.12.004.

    PMID: 41539872